InvestorsHub Logo

boston745

10/05/16 2:59 PM

#7103 RE: TennisStar #7102

It seems shortsighted move but you have to do what you have to do.
I think you are ignoring that they signed 20 new distributors (sales trajectory I was speaking of). I guess all the talk of having sufficient scientific evidence to assist distributors with sales was just marketing speak.

Amedica does not live and die by CsC. they have many products for sale and more pending. I for one am excited for their porous 3d printed model which I bet they apply for clearance next year.

Since you ignored this point, let me again point out that CsC has nothing to do with the Weigao deal nor Japan market. CsC is more beneficial then it is a hindrance.

Your overall bearish narrative seems exaggerated.

boston745

10/05/16 3:39 PM

#7107 RE: TennisStar #7102

Gone2Ground,

As far as today's price action is concerned, I call "shenanigans". News hits at 9:15 and there is no real price action for 45 minutes? Suddenly at 10 am EST, the dump begins? Smells like shearing sheep to me.

Personally, CsC denial would suck because I want it available for my dad whenever they decide its time for his next back surgery. What grounds would I have to blame management though? If anything my anger would be directed toward the FDA, at least until i see evidence indicating FDA did the right thing. For now, evidence is CSC is safely used in Europe and clinical trial evidence shows no safety concerns.